Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Date of 148 reexam of non-final action

I do believe the company has been holding signings back all along for strategic reasons. A prime example is immediately after the end of the Markman hearing, Nokia was announced as a new licensee.

Share
New Message
Please login to post a reply